<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Dialysis-related factors that may influence recovery of kidney function in acute kidney injury (acute renal failure)</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Dialysis-related factors that may influence recovery of kidney function in acute kidney injury (acute renal failure)</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Dialysis-related factors that may influence recovery of kidney function in acute kidney injury (acute renal failure)</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Edward D Siew, MD, MSCI</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Thomas A Golper, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Steve J Schwab, MD, FACP, FASN</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Paul M Palevsky, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Eric N Taylor, MD, MSc, FASN</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Oct 25, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Dialysis-requiring acute kidney injury (AKI-D) affects a large percentage of hospitalized and, particularly, critically ill patients [<a href="#rid1">1-6</a>]. The incidence has increased by 10 percent per year and affects approximately 0.4 percent of hospitalized patients and between 3 to 13 percent of critically ill patients [<a href="#rid1">1-6</a>].</p><p>The reasons for this growth are not known, though an aging population, broadening array of nephrotoxins, growth in conditions associated with AKI such as sepsis, and liberalization of thresholds to initiate kidney replacement therapy (KRT) are likely contributors [<a href="#rid7">7-10</a>].</p><p>Patients who survive AKI-D are at risk for permanent loss of kidney function and poor quality of life [<a href="#rid11">11-16</a>]. Cardiovascular risks and mortality are increased when kidney function does not recover [<a href="#rid17">17,18</a>], and growing attention is being paid toward optimizing outcomes after AKI [<a href="#rid19">19</a>].</p><p>This topic reviews dialysis-related factors that may influence the recovery from AKI-D. Overall outcomes of AKI and patient-related risk factors that may affect recovery of kidney function are discussed elsewhere:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/7225.html" rel="external">"Kidney and patient outcomes after acute kidney injury in adults", section on 'Degree of recovery'</a>.)</p><p></p><p>The indications, prescriptions, dose, and modalities of KRT in AKI are discussed separately:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/1927.html" rel="external">"Kidney replacement therapy (dialysis) in acute kidney injury in adults: Indications, timing, and dialysis dose"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/1852.html" rel="external">"Kidney replacement therapy (dialysis) in acute kidney injury: Metabolic and hemodynamic considerations"</a>.)</p><p></p><p class="headingAnchor" id="H3314358152"><span class="h1">DIALYSIS-RELATED FACTORS</span><span class="headingEndMark"> — </span>Dialysis–related factors that may influence recovery from AKI include recurrent intradialytic hypotension, management of fluid overload, increased susceptibility to infection, and challenges associated with appropriate dosing of medication. Nutritional factors and characteristics of the dialysis membrane may also play a role in the likelihood of kidney recovery.</p><p class="headingAnchor" id="H1561826206"><span class="h2">Repeated episodes of hypotension</span><span class="headingEndMark"> — </span>Hypotension is a common complication of hemodialysis. (See  <a class="medical medical_review" href="/d/html/1945.html" rel="external">"Intradialytic hypotension in an otherwise stable patient"</a>.)</p><p>Hypotension can cause kidney injury. (See  <a class="medical medical_review" href="/d/html/7228.html" rel="external">"Pathogenesis and etiology of ischemic acute tubular necrosis", section on 'Etiology'</a>.)</p><p>The effects of hypotension may be more pronounced among patients who already have acute tubular necrosis (ATN), which renders the kidney sensitive to diminished perfusion in preclinical studies. Normal kidneys vasodilate in the presence of ischemia as part of the autoregulatory response to maintain renal blood flow and glomerular filtration rate (GFR). Autoregulation is impaired in ATN, possibly because vascular endothelial injury reduces the release of vasodilating substances such as prostacyclin and nitric oxide [<a href="#rid20">20-22</a>]. As a result, recurrent ischemic tubular injury may be more likely to occur among patients treated with dialysis, thereby delaying the recovery of function [<a href="#rid23">23-26</a>].</p><p>The modality of kidney replacement therapy (KRT) may influence the likelihood of recovery because of the degree to which each modality causes hypotension. As an example, fluid and solute removal is slower and hypotension is less common with peritoneal dialysis and other continuous kidney replacement therapies (CKRTs) compared with intermittent hemodialysis. However, data do not conclusively support the superiority of any particular mode of KRT on kidney recovery in adult patients with AKI. (See  <a class="medical medical_review" href="/d/html/1927.html" rel="external">"Kidney replacement therapy (dialysis) in acute kidney injury in adults: Indications, timing, and dialysis dose", section on 'Optimal modality'</a>.)</p><p class="headingAnchor" id="H1161051139"><span class="h2">Management of fluid overload</span><span class="headingEndMark"> — </span>In patients with AKI-D, the optimal strategy for managing fluid overload has not yet been defined [<a href="#rid27">27</a>]. Several observational studies in critically ill cohorts suggest that higher rates of ultrafiltration are associated with a longer time to independence from KRT and with mortality [<a href="#rid28">28-31</a>]. However, fluid overload itself at the time of KRT initiation and during the KRT course also is associated with lower rates of kidney recovery and mortality [<a href="#rid32">32-36</a>].</p><p>Recent international surveys of critical care clinicians and nephrologists have demonstrated a wide heterogeneity in the management of fluid overload in patients with AKI-D [<a href="#rid37">37,38</a>], highlighting the need for clinical trials to define the optimal rates, targets, and methods of assessment of fluid removal among patients with AKI-D and fluid overload.</p><p class="headingAnchor" id="H3730476840"><span class="h2">Infection risk</span><span class="headingEndMark"> — </span>Sepsis may further injure the kidneys and therefore delay recovery. Patients who experience AKI are at high risk for infection. In one study of 618 critically ill patients, 40 percent of patients developed sepsis after developing AKI [<a href="#rid39">39</a>]. Predictors of incident sepsis after AKI included prolonged oliguria (≥3 days), higher severity of illness, fluid accumulation (&gt;25 percent of post-AKI days with cumulative fluid balance &gt;10 percent of body weight), invasive nonsurgical procedures after AKI, and receiving dialysis. The reasons for increased infection risk are not known but may be related to immune dysfunction and fluid overload [<a href="#rid40">40</a>].</p><p>In addition, the provision of dialysis may be associated with an increased risk for sepsis. In the study cited above, compared with patients who had AKI but did not develop sepsis, septic patients were more likely to have been dialyzed (70 versus 50 percent) [<a href="#rid39">39</a>].</p><p>The mechanism by which dialysis may increase the risk for sepsis is not known but may, in part, be related to the hemodialysis catheter and its attendant risk for bacteremia (see  <a class="medical medical_review" href="/d/html/3806.html" rel="external">"Intravascular catheter-related infection: Epidemiology, pathogenesis, and microbiology"</a>). In one trial comparing an early or delayed strategy of KRT initiation in critically ill patients, catheter-related bloodstream infections were increased in patients in the early initiation group (10 versus 5 percent) [<a href="#rid41">41</a>].</p><p>Other dialysis-related factors that may increase infection risk include the prolongation of hospitalization and, possibly, rare exposure to endotoxin or bacteria through the dialyzer membrane [<a href="#rid39">39,42,43</a>]. (See <a class="local">'Characteristics of the dialysis membrane'</a> below.)</p><p>There may be an increase in infection-related morbidity and mortality related to subtherapeutic antibiotic serum and tissue concentrations among patients who are on dialysis and develop infection [<a href="#rid42">42-46</a>]. Subtherapeutic antibiotic concentration is due to dialytic clearance of the antibiotic or reductions in the administered dose. Ongoing changes in kidney function or volume of distribution render the appropriate dosing of antibiotics challenging [<a href="#rid44">44-46</a>].</p><p class="headingAnchor" id="H3151152721"><span class="h2">Exposure to nephrotoxic medications</span><span class="headingEndMark"> — </span>Patients with dialysis-requiring AKI (AKI-D) may be more susceptible to nephrotoxic injury. The increased risk is related to the administration of nephrotoxins (either drugs or contrast medium) in the setting of diminished clearance, a higher likelihood of drug-drug interactions due to the increased number of concomitant medical exposures, an already injured parenchyma, and dialysis-induced volume depletion. The susceptibility to nephrotoxin injury may also be higher in older patients who are on multiple medications.</p><p class="headingAnchor" id="H2021353231"><span class="h2">Nutritional factors</span><span class="headingEndMark"> — </span>Providing adequate nutrition to patients with AKI-D therapy is challenging. (See  <a class="medical medical_review" href="/d/html/14035.html" rel="external">"Overview of the management of acute kidney injury (AKI) in adults", section on 'Managing nutrition'</a>.)</p><p>Patients with AKI, particularly those requiring dialysis, are at high risk for protein-energy wasting due to the catabolic effects of illness and as nutrients, particularly amino acids, are lost during dialysis. Observational studies have estimated that mean amino acid loss during KRT can be up to 23 grams per day, depending upon the modality [<a href="#rid47">47-50</a>].</p><p>Few studies have assessed the impact of providing nutritional support on recovery of kidney function in this population. The Early <a class="drug drug_general" data-topicid="10307" href="/d/drug information/10307.html" rel="external">Parenteral Nutrition</a> Completing Enteral Nutrition in Adult Critically Ill Patients (EPaNIC) trial randomly assigned 4640 critically ill patients already receiving enteral nutrition to early initiation of parenteral nutrition (within 48 hours of intensive care unit [ICU] admission) or later initiation (after seven days in the ICU) [<a href="#rid51">51</a>]. Although there was no difference in the overall proportion of patients who required KRT, the duration of KRT was shorter in the late-initiation compared with the early-initiation group (7 versus 10 days, respectively). Further studies are needed to adequately address the impact of nutrition on recovery of kidney function in AKI-D. (See  <a class="medical medical_review" href="/d/html/1617.html" rel="external">"Nutrition support in intubated critically ill adult patients: Initial evaluation and prescription"</a>.)</p><p class="headingAnchor" id="H3048702934"><span class="h2">Characteristics of the dialysis membrane</span><span class="headingEndMark"> — </span>Two variables of dialysis membranes have been suggested to affect kidney recovery. These include membrane biocompatibility and the degree to which membranes allow the back-transport from dialysate to blood of potentially harmful waterborne molecules (ie, high-flux versus low-flux membranes). These variables are discussed here.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Membrane biocompatibility </strong>– There are three types of dialyzer membranes, including cellulose, substituted cellulose, and synthetic noncellulose. Cellulose membranes (cuprophan or cuprophane) are considered bioincompatible, meaning that exposure to the membrane activates complement. Substituted cellulose and noncellulose membranes are more biocompatible. (See  <a class="medical medical_review" href="/d/html/1873.html" rel="external">"Clinical consequences of hemodialysis membrane biocompatibility", section on 'Types of hemodialysis membranes'</a>.)</p><p></p><p class="bulletIndent1">The use of biocompatible membranes may be associated with improved rates of recovery of kidney function [<a href="#rid52">52-54</a>], although not all studies have shown this [<a href="#rid55">55-57</a>].</p><p></p><p class="bulletIndent1">This is largely of historical concern since bioincompatible membranes are rarely used today (due to a reduction in cost of biocompatible membranes and due to concerns about biocompatibility). The use of biocompatible membranes has been widely adopted into contemporary practice and is recommended in the Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guidelines for AKI [<a href="#rid58">58,59</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Membrane flux </strong>– Membranes can be low or high flux. High-flux membranes contain large pores that allow for enhanced permeability of larger molecules [<a href="#rid60">60</a>]. Although large pores can enhance removal of putative toxins, they can also allow the back-transport (from dialysate to blood) of potentially harmful waterborne substances (such as bacteria or endotoxin) or increased loss of potentially beneficial ones. The risk of contamination from water with bacteria or endotoxin is minimized, but may not be eradicated, by the use of highly purified dialysate water. (See  <a class="medical medical_review" href="/d/html/1896.html" rel="external">"Assuring water quality for hemodialysis"</a>.)</p><p></p><p class="bulletIndent1">Only a few studies have compared low- and high-flux membranes among patients with AKI-D, and most found no difference in terms of survival or recovery of kidney function [<a href="#rid56">56,57,61</a>]. Definitive studies of high-flux dialysis are available from the chronic hemodialysis population and suggest no difference in outcomes [<a href="#rid62">62,63</a>]. (See  <a class="medical medical_review" href="/d/html/1844.html" rel="external">"Dialysis modality and patient outcome"</a>.)</p><p></p><p class="headingAnchor" id="H555741265"><span class="h2">Timing of initiation and dose of dialysis</span><span class="headingEndMark"> — </span>The optimal timing of dialysis initiation for patients who experience severe AKI in the absence of immediate, life-threatening complications is not known [<a href="#rid64">64,65</a>]. Some early observational studies suggested improved kidney recovery with early versus delayed initiation of KRT [<a href="#rid66">66-74</a>]. However, results have not been consistent, and subsequent trials have not demonstrated a benefit of earlier initiation on dialysis dependence [<a href="#rid41">41,75-78</a>]. This issue is discussed elsewhere. (See  <a class="medical medical_review" href="/d/html/1927.html" rel="external">"Kidney replacement therapy (dialysis) in acute kidney injury in adults: Indications, timing, and dialysis dose", section on 'Timing of elective initiation'</a>.)</p><p>High-quality evidence also suggests that a delivered dose of dialysis beyond a minimum acceptable threshold does not increase the likelihood of recovery [<a href="#rid79">79,80</a>]. These studies are discussed elsewhere. (See  <a class="medical medical_review" href="/d/html/1927.html" rel="external">"Kidney replacement therapy (dialysis) in acute kidney injury in adults: Indications, timing, and dialysis dose", section on 'Optimal dosing'</a>.)</p><p class="headingAnchor" id="H652882781"><span class="h1">FALL IN URINE OUTPUT</span><span class="headingEndMark"> — </span>A reduction in urine output is sometimes observed following initiation of hemodialysis in AKI. In a multicenter, randomized trial that compared high-intensity versus low-intensity kidney replacement therapy (KRT) among critically ill patients, higher-intensity KRT was associated with higher risk of a decline in urine output (relative risk [RR] 1.29, 95% CI 1.10-1.51) [<a href="#rid81">81</a>]. However, these differences did not associate with differences in dialysis dependence at day 28 or 60.</p><p>Both removal of excess volume and solutes retained in uremia may contribute to this response [<a href="#rid82">82</a>]. Urea may also be a surrogate marker of other substances that are removed by dialysis that stimulate urine output. (See  <a class="medical medical_review" href="/d/html/1941.html" rel="external">"Residual kidney function in kidney failure"</a>.)</p><p>The clinical significance of this is unclear. A patient with dialysis-requiring AKI (AKI-D) typically has few remaining functioning nephrons [<a href="#rid83">83</a>]. The decline in urine output following dialysis may reflect an increase in tubular reabsorption in these few nephrons. Even if the function of these nephrons became impaired (perhaps because slow flow promotes obstruction by tubular debris), an adverse impact of the fall in urine output on repair of other tubules and restoration of function in nonfunctioning nephrons has not been demonstrated.</p><p class="headingAnchor" id="H2233185958"><span class="h1">PROTECTING THE KIDNEY FROM FURTHER INJURY</span><span class="headingEndMark"> — </span>It is important to prevent further injury to the kidney.</p><p>General measures to prevent ongoing kidney injury among dialysis-requiring AKI (AKI-D) patients are the same as for critically ill patients who have nondialysis-requiring AKI. (See  <a class="medical medical_review" href="/d/html/7224.html" rel="external">"Possible prevention and therapy of ischemic acute tubular necrosis", section on 'Our approach'</a>.)</p><p>Preventive measures that are specifically related to dialysis include minimizing hypotension during dialysis, avoiding aggressive ultrafiltration rates when feasible, monitoring hemodynamics closely during ultrafiltration, preventing catheter-related infection by minimizing duration of use for nontunneled catheters and optimizing infection control measures, and limiting exposure to nephrotoxins as much as possible. (See  <a class="medical medical_review" href="/d/html/1945.html" rel="external">"Intradialytic hypotension in an otherwise stable patient"</a> and  <a class="medical medical_review" href="/d/html/1843.html" rel="external">"Central venous catheters for acute and chronic hemodialysis access and their management"</a> and  <a class="medical medical_review" href="/d/html/15671.html" rel="external">"Routine care and maintenance of intravenous devices"</a>.) </p><p>We also advise frequent evaluation of kidney function by assessing urine output and obtaining interdialytic measurements of serum creatinine. In some patients with prolonged acute illness, loss of muscle mass and reduced creatinine generation may lead to an overestimate of kidney function as assessed by creatinine-based estimated glomerular filtration rate (eGFR) equations. Using measurements of creatinine clearance or serum cystatin C in such patients may provide more accurate assessments of kidney function. (See  <a class="medical medical_review" href="/d/html/1927.html" rel="external">"Kidney replacement therapy (dialysis) in acute kidney injury in adults: Indications, timing, and dialysis dose", section on 'Discontinuation of therapy'</a> and  <a class="medical medical_review" href="/d/html/2359.html" rel="external">"Assessment of kidney function", section on 'Assessment of GFR'</a>.)</p><p>Although indwelling urinary catheters help quantify urine output and can guide decision-making regarding dialysis, their continued use must be weighed against the risk of catheter-associated urinary tract infection. Thus, when these are used, there should be frequent ongoing assessment of their need. Other methods to assess urine output, such as bedside bladder ultrasound with or without intermittent catheterization, are preferred instead.</p><p>Medications should be frequently reviewed throughout the course of AKI. For potentially nephrotoxic drugs that are deemed necessary, frequent therapeutic drug monitoring (eg, <a class="drug drug_general" data-topicid="10037" href="/d/drug information/10037.html" rel="external">vancomycin</a>, aminoglycosides) should be performed and the lowest effective dose utilized [<a href="#rid84">84</a>]. Medication reviews should also include doses of new and preexisting oral medications (including potential over-the-counter nephrotoxins such as nonsteroidal anti-inflammatory drugs [NSAIDs] and herbal medications) as many of these patients will continue to be treated as outpatients while awaiting recovery.</p><p>There is little evidence to guide the appropriate use of blood pressure medications during recovery from AKI-D. The benefits of aggressive blood pressure control, most of which are long term, should be weighed against the individual risk for hypotension and its potential adverse impact on kidney recovery. In general, we apply a cautious approach to blood pressure control with the goal of minimizing the risk for hypotension. The decision to continue or discontinue angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) during recovery from AKI-D has not been directly addressed in existing clinical trials. However, concerns about worsening hypotension, hyperkalemia, blunting of renal autoregulation, and masking of potential recovery generally favor discontinuation of these agents while recovery is still being considered. Although one observational study reported that continued use of ACE inhibitors or ARBs following AKI was associated with increases in hospitalizations for kidney-related complications including AKI and hyperkalemia [<a href="#rid85">85</a>], subsequent studies did not observe this association [<a href="#rid86">86,87</a>]. Notably, these studies primarily included patients with nondialysis-requiring AKI, in whom such complications would generally occur less frequently than in patients with more severe AKI. Further studies in this area are needed. (See  <a class="medical medical_review" href="/d/html/4814.html" rel="external">"Perioperative medication management", section on 'ACE inhibitors and angiotensin II receptor blockers'</a>.)</p><p>The necessity of nephrotoxic procedures (eg, iodinated contrast exposure) should also be carefully weighed against the potential risk for further injury. The timing of procedures should also be considered, if possible; delaying the exposure to contrast for nonurgent indications or procedures until recovery of kidney function may be of benefit among patients who are considered likely to recover. (See  <a class="medical medical_review" href="/d/html/7221.html" rel="external">"Prevention of contrast-associated acute kidney injury related to angiography"</a>.)</p><p>As noted above, biocompatible dialysis membranes should be used, if available. We generally use high-flux membranes, although low-flux membranes should be used if high-quality water is not available. (See <a class="local">'Characteristics of the dialysis membrane'</a> above.)</p><p>It is important to monitor closely for kidney recovery so that kidney replacement therapy (KRT) may be discontinued. This is discussed elsewhere:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/1927.html" rel="external">"Kidney replacement therapy (dialysis) in acute kidney injury in adults: Indications, timing, and dialysis dose", section on 'Discontinuation of therapy'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/1854.html" rel="external">"Acute hemodialysis prescription", section on 'Management during recovery of kidney function'</a>.)</p><p></p><p>Recommendations regarding dialysis modality, timing and dose of dialysis, anticoagulation, and optimal nutrition are all discussed elsewhere:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/1927.html" rel="external">"Kidney replacement therapy (dialysis) in acute kidney injury in adults: Indications, timing, and dialysis dose"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/16855.html" rel="external">"Anticoagulation for continuous kidney replacement therapy"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/14035.html" rel="external">"Overview of the management of acute kidney injury (AKI) in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/1840.html" rel="external">"Anticoagulation for the hemodialysis procedure"</a>.)</p><p></p><p class="headingAnchor" id="H1751615555"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Dialysis-related factors</strong> – Dialysis–related factors that may impair recovery from acute kidney injury (AKI) include intradialytic hypotension; increased risk of sepsis, particularly related to vascular access; and challenges associated with appropriate dosing of medication. Issues related to nutritional factors and characteristics of the dialysis membrane may also play a role. (See <a class="local">'Dialysis-related factors'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nondialysis factors</strong> – Nondialysis-related measures to prevent ongoing kidney injury among dialysis-requiring AKI (AKI-D) patients are generally the same as for critically ill patients who have nondialysis-requiring AKI. (See <a class="local">'Protecting the kidney from further injury'</a> above and  <a class="medical medical_review" href="/d/html/7224.html" rel="external">"Possible prevention and therapy of ischemic acute tubular necrosis", section on 'Our approach'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Preventive measures</strong> – Preventive measures that are specifically related to dialysis include minimizing hypotension during dialysis, preventing catheter-related infection, limiting exposure to nephrotoxins, and using biocompatible high-flux membranes. (See <a class="local">'Protecting the kidney from further injury'</a> above and <a class="local">'Characteristics of the dialysis membrane'</a> above and  <a class="medical medical_review" href="/d/html/1945.html" rel="external">"Intradialytic hypotension in an otherwise stable patient"</a> and  <a class="medical medical_review" href="/d/html/15671.html" rel="external">"Routine care and maintenance of intravenous devices"</a>.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Hoste EA, Bagshaw SM, Bellomo R, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med 2015; 41:1411.</a></li><li><a class="nounderline abstract_t">Uchino S. The epidemiology of acute renal failure in the world. Curr Opin Crit Care 2006; 12:538.</a></li><li><a class="nounderline abstract_t">Hsu RK, McCulloch CE, Dudley RA, et al. Temporal changes in incidence of dialysis-requiring AKI. J Am Soc Nephrol 2013; 24:37.</a></li><li><a class="nounderline abstract_t">Waikar SS, Curhan GC, Wald R, et al. Declining mortality in patients with acute renal failure, 1988 to 2002. J Am Soc Nephrol 2006; 17:1143.</a></li><li><a class="nounderline abstract_t">Hsu CY, McCulloch CE, Fan D, et al. Community-based incidence of acute renal failure. Kidney Int 2007; 72:208.</a></li><li><a class="nounderline abstract_t">Wald R, McArthur E, Adhikari NK, et al. Changing incidence and outcomes following dialysis-requiring acute kidney injury among critically ill adults: a population-based cohort study. Am J Kidney Dis 2015; 65:870.</a></li><li><a class="nounderline abstract_t">Hsu RK, McCulloch CE, Heung M, et al. Exploring Potential Reasons for the Temporal Trend in Dialysis-Requiring AKI in the United States. Clin J Am Soc Nephrol 2016; 11:14.</a></li><li><a class="nounderline abstract_t">Siew ED, Davenport A. The growth of acute kidney injury: a rising tide or just closer attention to detail? Kidney Int 2015; 87:46.</a></li><li><a class="nounderline abstract_t">Dombrovskiy VY, Martin AA, Sunderram J, Paz HL. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med 2007; 35:1244.</a></li><li><a class="nounderline abstract_t">Siddiqui NF, Coca SG, Devereaux PJ, et al. Secular trends in acute dialysis after elective major surgery--1995 to 2009. CMAJ 2012; 184:1237.</a></li><li><a class="nounderline abstract_t">Lo LJ, Go AS, Chertow GM, et al. Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease. Kidney Int 2009; 76:893.</a></li><li><a class="nounderline abstract_t">Wald R, Quinn RR, Luo J, et al. Chronic dialysis and death among survivors of acute kidney injury requiring dialysis. JAMA 2009; 302:1179.</a></li><li><a class="nounderline abstract_t">Coca SG, Singanamala S, Parikh CR. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int 2012; 81:442.</a></li><li><a class="nounderline abstract_t">James MT, Ghali WA, Tonelli M, et al. Acute kidney injury following coronary angiography is associated with a long-term decline in kidney function. Kidney Int 2010; 78:803.</a></li><li><a class="nounderline abstract_t">Chawla LS, Eggers PW, Star RA, Kimmel PL. Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med 2014; 371:58.</a></li><li><a class="nounderline abstract_t">Johansen KL, Smith MW, Unruh ML, et al. Predictors of health utility among 60-day survivors of acute kidney injury in the Veterans Affairs/National Institutes of Health Acute Renal Failure Trial Network Study. Clin J Am Soc Nephrol 2010; 5:1366.</a></li><li><a class="nounderline abstract_t">Hsu CY, Chertow GM, McCulloch CE, et al. Nonrecovery of kidney function and death after acute on chronic renal failure. Clin J Am Soc Nephrol 2009; 4:891.</a></li><li><a class="nounderline abstract_t">Sawhney S, Mitchell M, Marks A, et al. Long-term prognosis after acute kidney injury (AKI): what is the role of baseline kidney function and recovery? A systematic review. BMJ Open 2015; 5:e006497.</a></li><li><a class="nounderline abstract_t">Siew ED, Liu KD, Bonn J, et al. Improving Care for Patients after Hospitalization with AKI. J Am Soc Nephrol 2020; 31:2237.</a></li><li><a class="nounderline abstract_t">Conger JD, Robinette JB, Schrier RW. Smooth muscle calcium and endothelium-derived relaxing factor in the abnormal vascular responses of acute renal failure. J Clin Invest 1988; 82:532.</a></li><li><a class="nounderline abstract_t">Conger JD, Robinette JB, Hammond WS. Differences in vascular reactivity in models of ischemic acute renal failure. Kidney Int 1991; 39:1087.</a></li><li><a class="nounderline abstract_t">Kelleher SP, Robinette JB, Miller F, Conger JD. Effect of hemorrhagic reduction in blood pressure on recovery from acute renal failure. Kidney Int 1987; 31:725.</a></li><li><a class="nounderline abstract_t">Solez K, Morel-Maroger L, Sraer JD. The morphology of "acute tubular necrosis" in man: analysis of 57 renal biopsies and a comparison with the glycerol model. Medicine (Baltimore) 1979; 58:362.</a></li><li><a class="nounderline abstract_t">Myers BD, Moran SM. Hemodynamically mediated acute renal failure. N Engl J Med 1986; 314:97.</a></li><li><a class="nounderline abstract_t">Venkatachalam MA, Griffin KA, Lan R, et al. Acute kidney injury: a springboard for progression in chronic kidney disease. Am J Physiol Renal Physiol 2010; 298:F1078.</a></li><li><a class="nounderline abstract_t">Abuelo JG. Normotensive ischemic acute renal failure. N Engl J Med 2007; 357:797.</a></li><li><a class="nounderline abstract_t">Murugan R, Bellomo R, Palevsky PM, Kellum JA. Ultrafiltration in critically ill patients treated with kidney replacement therapy. Nat Rev Nephrol 2021; 17:262.</a></li><li><a class="nounderline abstract_t">Murugan R, Kerti SJ, Chang CH, et al. Association of Net Ultrafiltration Rate With Mortality Among Critically Ill Adults With Acute Kidney Injury Receiving Continuous Venovenous Hemodiafiltration: A Secondary Analysis of the Randomized Evaluation of Normal vs Augmented Level (RENAL) of Renal Replacement Therapy Trial. JAMA Netw Open 2019; 2:e195418.</a></li><li><a class="nounderline abstract_t">Naorungroj T, Neto AS, Zwakman-Hessels L, et al. Mediators of the Impact of Hourly Net Ultrafiltration Rate on Mortality in Critically Ill Patients Receiving Continuous Renal Replacement Therapy. Crit Care Med 2020; 48:e934.</a></li><li><a class="nounderline abstract_t">Murugan R, Kerti SJ, Chang CH, et al. Association between Net Ultrafiltration Rate and Renal Recovery among Critically Ill Adults with Acute Kidney Injury Receiving Continuous Renal Replacement Therapy: An Observational Cohort Study. Blood Purif 2022; 51:397.</a></li><li><a class="nounderline abstract_t">Pajewski R, Gipson P, Heung M. Predictors of post-hospitalization recovery of renal function among patients with acute kidney injury requiring dialysis. Hemodial Int 2018; 22:66.</a></li><li><a class="nounderline abstract_t">Bouchard J, Soroko SB, Chertow GM, et al. Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int 2009; 76:422.</a></li><li><a class="nounderline abstract_t">Payen D, de Pont AC, Sakr Y, et al. A positive fluid balance is associated with a worse outcome in patients with acute renal failure. Crit Care 2008; 12:R74.</a></li><li><a class="nounderline abstract_t">Kim IY, Kim S, Ye BM, et al. Effect of fluid overload on survival in patients with sepsis-induced acute kidney injury receiving continuous renal replacement therapy. Sci Rep 2023; 13:2796.</a></li><li><a class="nounderline abstract_t">Heung M, Wolfgram DF, Kommareddi M, et al. Fluid overload at initiation of renal replacement therapy is associated with lack of renal recovery in patients with acute kidney injury. Nephrol Dial Transplant 2012; 27:956.</a></li><li><a class="nounderline abstract_t">RENAL Replacement Therapy Study Investigators, Bellomo R, Cass A, et al. An observational study fluid balance and patient outcomes in the Randomized Evaluation of Normal vs. Augmented Level of Replacement Therapy trial. Crit Care Med 2012; 40:1753.</a></li><li><a class="nounderline abstract_t">Chen H, Murugan R. Survey of U.S. Critical Care Practitioners on Net Ultrafiltration Prescription and Practice among Critically Ill Patients Receiving Kidney Replacement Therapy. J Crit Care Med (Targu Mures) 2021; 7:272.</a></li><li><a class="nounderline abstract_t">Ledoux-Hutchinson L, Wald R, Malbrain MLNG, et al. Fluid Management for Critically Ill Patients with Acute Kidney Injury Receiving Kidney Replacement Therapy: An International Survey. Clin J Am Soc Nephrol 2023; 18:705.</a></li><li><a class="nounderline abstract_t">Mehta RL, Bouchard J, Soroko SB, et al. Sepsis as a cause and consequence of acute kidney injury: Program to Improve Care in Acute Renal Disease. Intensive Care Med 2011; 37:241.</a></li><li><a class="nounderline abstract_t">Himmelfarb J, Le P, Klenzak J, et al. Impaired monocyte cytokine production in critically ill patients with acute renal failure. Kidney Int 2004; 66:2354.</a></li><li><a class="nounderline abstract_t">Gaudry S, Hajage D, Schortgen F, et al. Initiation Strategies for Renal-Replacement Therapy in the Intensive Care Unit. N Engl J Med 2016; 375:122.</a></li><li><a class="nounderline abstract_t">Roberts DM, Liu X, Roberts JA, et al. A multicenter study on the effect of continuous hemodiafiltration intensity on antibiotic pharmacokinetics. Crit Care 2015; 19:84.</a></li><li><a class="nounderline abstract_t">Mueller BA, Pasko DA, Sowinski KM. Higher renal replacement therapy dose delivery influences on drug therapy. Artif Organs 2003; 27:808.</a></li><li><a class="nounderline abstract_t">Eyler RF, Mueller BA, Medscape. Antibiotic dosing in critically ill patients with acute kidney injury. Nat Rev Nephrol 2011; 7:226.</a></li><li><a class="nounderline abstract_t">Fissell WH. Antimicrobial dosing in acute renal replacement. Adv Chronic Kidney Dis 2013; 20:85.</a></li><li><a class="nounderline abstract_t">Nolin TD, Aronoff GR, Fissell WH, et al. Pharmacokinetic assessment in patients receiving continuous RRT: perspectives from the Kidney Health Initiative. Clin J Am Soc Nephrol 2015; 10:159.</a></li><li><a class="nounderline abstract_t">Ikizler TA, Flakoll PJ, Parker RA, Hakim RM. Amino acid and albumin losses during hemodialysis. Kidney Int 1994; 46:830.</a></li><li><a class="nounderline abstract_t">Umber A, Wolley MJ, Golper TA, et al. Amino acid losses during sustained low efficiency dialysis in critically ill patients with acute kidney injury. Clin Nephrol 2014; 81:93.</a></li><li><a class="nounderline abstract_t">Mokrzycki MH, Kaplan AA. Protein losses in continuous renal replacement therapies. J Am Soc Nephrol 1996; 7:2259.</a></li><li><a class="nounderline abstract_t">Frankenfield DC, Reynolds HN. Nutritional effect of continuous hemodiafiltration. Nutrition 1995; 11:388.</a></li><li><a class="nounderline abstract_t">Casaer MP, Mesotten D, Hermans G, et al. Early versus late parenteral nutrition in critically ill adults. N Engl J Med 2011; 365:506.</a></li><li><a class="nounderline abstract_t">Himmelfarb J, Zaoui P, Hakim R. Modulation of granulocyte LAM-1 and MAC-1 during dialysis--a prospective, randomized controlled trial. Kidney Int 1992; 41:388.</a></li><li><a class="nounderline abstract_t">Hakim RM, Wingard RL, Parker RA. Effect of the dialysis membrane in the treatment of patients with acute renal failure. N Engl J Med 1994; 331:1338.</a></li><li><a class="nounderline abstract_t">Schiffl H, Lang SM, König A, et al. Biocompatible membranes in acute renal failure: prospective case-controlled study. Lancet 1994; 344:570.</a></li><li><a class="nounderline abstract_t">Subramanian S, Venkataraman R, Kellum JA. Influence of dialysis membranes on outcomes in acute renal failure: a meta-analysis. Kidney Int 2002; 62:1819.</a></li><li><a class="nounderline abstract_t">Gastaldello K, Melot C, Kahn RJ, et al. Comparison of cellulose diacetate and polysulfone membranes in the outcome of acute renal failure. A prospective randomized study. Nephrol Dial Transplant 2000; 15:224.</a></li><li><a class="nounderline abstract_t">Alonso A, Lau J, Jaber BL. Biocompatible hemodialysis membranes for acute renal failure. Cochrane Database Syst Rev 2008; :CD005283.</a></li><li><a class="nounderline abstract_t">KDIGO clinical practice guidelines for acute kidney injury. Kidney Int Suppl 2012; 2.</a></li><li><a class="nounderline abstract_t">Palevsky PM, Liu KD, Brophy PD, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. Am J Kidney Dis 2013; 61:649.</a></li><li class="breakAll">Marshall, MR, Golper, TA. Intermittent Hemodialysis in Intensive Care in Nephrology, Murray, P, Brady, H, Hall, J (Eds), Taylor &amp; Francis, Oxford, UK 2005.</li><li><a class="nounderline abstract_t">Ponikvar JB, Rus RR, Kenda RB, et al. Low-flux versus high-flux synthetic dialysis membrane in acute renal failure: prospective randomized study. Artif Organs 2001; 25:946.</a></li><li><a class="nounderline abstract_t">Locatelli F, Martin-Malo A, Hannedouche T, et al. Effect of membrane permeability on survival of hemodialysis patients. J Am Soc Nephrol 2009; 20:645.</a></li><li><a class="nounderline abstract_t">Eknoyan G, Beck GJ, Cheung AK, et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 2002; 347:2010.</a></li><li><a class="nounderline abstract_t">Schneider AG, Bellomo R, Bagshaw SM, et al. Choice of renal replacement therapy modality and dialysis dependence after acute kidney injury: a systematic review and meta-analysis. Intensive Care Med 2013; 39:987.</a></li><li><a class="nounderline abstract_t">Ostermann M, Dickie H, Barrett NA. Renal replacement therapy in critically ill patients with acute kidney injury--when to start. Nephrol Dial Transplant 2012; 27:2242.</a></li><li><a class="nounderline abstract_t">Liu KD, Himmelfarb J, Paganini E, et al. Timing of initiation of dialysis in critically ill patients with acute kidney injury. Clin J Am Soc Nephrol 2006; 1:915.</a></li><li><a class="nounderline abstract_t">Bagshaw SM, Uchino S, Bellomo R, et al. Timing of renal replacement therapy and clinical outcomes in critically ill patients with severe acute kidney injury. J Crit Care 2009; 24:129.</a></li><li><a class="nounderline abstract_t">Karvellas CJ, Farhat MR, Sajjad I, et al. A comparison of early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury: a systematic review and meta-analysis. Crit Care 2011; 15:R72.</a></li><li><a class="nounderline abstract_t">Carl DE, Grossman C, Behnke M, et al. Effect of timing of dialysis on mortality in critically ill, septic patients with acute renal failure. Hemodial Int 2010; 14:11.</a></li><li><a class="nounderline abstract_t">Shiao CC, Wu VC, Li WY, et al. Late initiation of renal replacement therapy is associated with worse outcomes in acute kidney injury after major abdominal surgery. Crit Care 2009; 13:R171.</a></li><li><a class="nounderline abstract_t">Vaara ST, Reinikainen M, Wald R, et al. Timing of RRT based on the presence of conventional indications. Clin J Am Soc Nephrol 2014; 9:1577.</a></li><li><a class="nounderline abstract_t">Seabra VF, Balk EM, Liangos O, et al. Timing of renal replacement therapy initiation in acute renal failure: a meta-analysis. Am J Kidney Dis 2008; 52:272.</a></li><li><a class="nounderline abstract_t">Durmaz I, Yagdi T, Calkavur T, et al. Prophylactic dialysis in patients with renal dysfunction undergoing on-pump coronary artery bypass surgery. Ann Thorac Surg 2003; 75:859.</a></li><li><a class="nounderline abstract_t">Zarbock A, Kellum JA, Schmidt C, et al. Effect of Early vs Delayed Initiation of Renal Replacement Therapy on Mortality in Critically Ill Patients With Acute Kidney Injury: The ELAIN Randomized Clinical Trial. JAMA 2016; 315:2190.</a></li><li><a class="nounderline abstract_t">Bouman CS, Oudemans-Van Straaten HM, Tijssen JG, et al. Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial. Crit Care Med 2002; 30:2205.</a></li><li><a class="nounderline abstract_t">Jamale TE, Hase NK, Kulkarni M, et al. Earlier-start versus usual-start dialysis in patients with community-acquired acute kidney injury: a randomized controlled trial. Am J Kidney Dis 2013; 62:1116.</a></li><li><a class="nounderline abstract_t">STARRT-AKI Investigators, Canadian Critical Care Trials Group, Australian and New Zealand Intensive Care Society Clinical Trials Group, et al. Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury. N Engl J Med 2020; 383:240.</a></li><li><a class="nounderline abstract_t">Barbar SD, Clere-Jehl R, Bourredjem A, et al. Timing of Renal-Replacement Therapy in Patients with Acute Kidney Injury and Sepsis. N Engl J Med 2018; 379:1431.</a></li><li><a class="nounderline abstract_t">VA/NIH Acute Renal Failure Trial Network, Palevsky PM, Zhang JH, et al. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 2008; 359:7.</a></li><li><a class="nounderline abstract_t">RENAL Replacement Therapy Study Investigators, Bellomo R, Cass A, et al. Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 2009; 361:1627.</a></li><li><a class="nounderline abstract_t">Mc Causland FR, Asafu-Adjei J, Betensky RA, et al. Comparison of Urine Output among Patients Treated with More Intensive Versus Less Intensive RRT: Results from the Acute Renal Failure Trial Network Study. Clin J Am Soc Nephrol 2016; 11:1335.</a></li><li><a class="nounderline abstract_t">Yeh BP, Tomko DJ, Stacy WK, et al. Factors influencing sodium and water excretion in uremic man. Kidney Int 1975; 7:103.</a></li><li><a class="nounderline abstract_t">Finn WF. Nephron heterogeneity in polyuric acute renal failure. J Lab Clin Med 1981; 98:21.</a></li><li><a class="nounderline abstract_t">Smyth A, Tan KH, Hyman-Taylor P, et al. Once versus three-times daily regimens of tobramycin treatment for pulmonary exacerbations of cystic fibrosis--the TOPIC study: a randomised controlled trial. Lancet 2005; 365:573.</a></li><li><a class="nounderline abstract_t">Brar S, Ye F, James MT, et al. Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With Outcomes After Acute Kidney Injury. JAMA Intern Med 2018; 178:1681.</a></li><li><a class="nounderline abstract_t">Siew ED, Parr SK, Abdel-Kader K, et al. Renin-angiotensin aldosterone inhibitor use at hospital discharge among patients with moderate to severe acute kidney injury and its association with recurrent acute kidney injury and mortality. Kidney Int 2021; 99:1202.</a></li><li><a class="nounderline abstract_t">Brar S, Liu KD, Go AS, et al. Prospective Cohort Study of Renin-Angiotensin System Blocker Usage after Hospitalized Acute Kidney Injury. Clin J Am Soc Nephrol 2020; 16:26.</a></li></ol></div><div id="topicVersionRevision">Topic 1938 Version 28.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26162677" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17077683" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : The epidemiology of acute renal failure in the world.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23222124" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Temporal changes in incidence of dialysis-requiring AKI.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16495376" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Declining mortality in patients with acute renal failure, 1988 to 2002.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17507907" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Community-based incidence of acute renal failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25533599" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Changing incidence and outcomes following dialysis-requiring acute kidney injury among critically ill adults: a population-based cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26683890" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Exploring Potential Reasons for the Temporal Trend in Dialysis-Requiring AKI in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25229340" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : The growth of acute kidney injury: a rising tide or just closer attention to detail?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17414736" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22733671" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Secular trends in acute dialysis after elective major surgery--1995 to 2009.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19641480" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19755696" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Chronic dialysis and death among survivors of acute kidney injury requiring dialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22113526" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20686453" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Acute kidney injury following coronary angiography is associated with a long-term decline in kidney function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24988558" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Acute kidney injury and chronic kidney disease as interconnected syndromes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20507953" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Predictors of health utility among 60-day survivors of acute kidney injury in the Veterans Affairs/National Institutes of Health Acute Renal Failure Trial Network Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19406959" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Nonrecovery of kidney function and death after acute on chronic renal failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25564144" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Long-term prognosis after acute kidney injury (AKI): what is the role of baseline kidney function and recovery? A systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32912935" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Improving Care for Patients after Hospitalization with AKI.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3261301" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Smooth muscle calcium and endothelium-derived relaxing factor in the abnormal vascular responses of acute renal failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1895663" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Differences in vascular reactivity in models of ischemic acute renal failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3573537" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Effect of hemorrhagic reduction in blood pressure on recovery from acute renal failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/481195" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : The morphology of "acute tubular necrosis" in man: analysis of 57 renal biopsies and a comparison with the glycerol model.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3510383" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Hemodynamically mediated acute renal failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20200097" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Acute kidney injury: a springboard for progression in chronic kidney disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17715412" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Normotensive ischemic acute renal failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33177700" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Ultrafiltration in critically ill patients treated with kidney replacement therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31173127" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Association of Net Ultrafiltration Rate With Mortality Among Critically Ill Adults With Acute Kidney Injury Receiving Continuous Venovenous Hemodiafiltration: A Secondary Analysis of the Randomized Evaluation of Normal vs Augmented Level (RENAL) of Renal Replacement Therapy Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32885938" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Mediators of the Impact of Hourly Net Ultrafiltration Rate on Mortality in Critically Ill Patients Receiving Continuous Renal Replacement Therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34289471" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Association between Net Ultrafiltration Rate and Renal Recovery among Critically Ill Adults with Acute Kidney Injury Receiving Continuous Renal Replacement Therapy: An Observational Cohort Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28296033" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Predictors of post-hospitalization recovery of renal function among patients with acute kidney injury requiring dialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19436332" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18533029" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : A positive fluid balance is associated with a worse outcome in patients with acute renal failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36797439" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Effect of fluid overload on survival in patients with sepsis-induced acute kidney injury receiving continuous renal replacement therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21856761" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Fluid overload at initiation of renal replacement therapy is associated with lack of renal recovery in patients with acute kidney injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22610181" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : An observational study fluid balance and patient outcomes in the Randomized Evaluation of Normal vs. Augmented Level of Replacement Therapy trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34934817" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Survey of U.S. Critical Care Practitioners on Net Ultrafiltration Prescription and Practice among Critically Ill Patients Receiving Kidney Replacement Therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36975194" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Fluid Management for Critically Ill Patients with Acute Kidney Injury Receiving Kidney Replacement Therapy: An International Survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21152901" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Sepsis as a cause and consequence of acute kidney injury: Program to Improve Care in Acute Renal Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15569326" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Impaired monocyte cytokine production in critically ill patients with acute renal failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27181456" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Initiation Strategies for Renal-Replacement Therapy in the Intensive Care Unit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25881576" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : A multicenter study on the effect of continuous hemodiafiltration intensity on antibiotic pharmacokinetics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12940903" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Higher renal replacement therapy dose delivery influences on drug therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21343897" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Antibiotic dosing in critically ill patients with acute kidney injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23265600" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Antimicrobial dosing in acute renal replacement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25189923" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Pharmacokinetic assessment in patients receiving continuous RRT: perspectives from the Kidney Health Initiative.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7996804" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Amino acid and albumin losses during hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24290407" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Amino acid losses during sustained low efficiency dialysis in critically ill patients with acute kidney injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8915988" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Protein losses in continuous renal replacement therapies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8580582" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Nutritional effect of continuous hemodiafiltration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21714640" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Early versus late parenteral nutrition in critically ill adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1372668" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Modulation of granulocyte LAM-1 and MAC-1 during dialysis--a prospective, randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7935703" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Effect of the dialysis membrane in the treatment of patients with acute renal failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7914959" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Biocompatible membranes in acute renal failure: prospective case-controlled study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12371984" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Influence of dialysis membranes on outcomes in acute renal failure: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10648669" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Comparison of cellulose diacetate and polysulfone membranes in the outcome of acute renal failure. A prospective randomized study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18254074" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Biocompatible hemodialysis membranes for acute renal failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : KDIGO clinical practice guidelines for acute kidney injury</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23499048" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23499048" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11843761" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Low-flux versus high-flux synthetic dialysis membrane in acute renal failure: prospective randomized study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19092122" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Effect of membrane permeability on survival of hemodialysis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12490682" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Effect of dialysis dose and membrane flux in maintenance hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23443311" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Choice of renal replacement therapy modality and dialysis dependence after acute kidney injury: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22231034" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Renal replacement therapy in critically ill patients with acute kidney injury--when to start.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17699307" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Timing of initiation of dialysis in critically ill patients with acute kidney injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19272549" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Timing of renal replacement therapy and clinical outcomes in critically ill patients with severe acute kidney injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21352532" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : A comparison of early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20377649" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Effect of timing of dialysis on mortality in critically ill, septic patients with acute renal failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19878554" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Late initiation of renal replacement therapy is associated with worse outcomes in acute kidney injury after major abdominal surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25107952" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Timing of RRT based on the presence of conventional indications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18562058" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Timing of renal replacement therapy initiation in acute renal failure: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12645707" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Prophylactic dialysis in patients with renal dysfunction undergoing on-pump coronary artery bypass surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27209269" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Effect of Early vs Delayed Initiation of Renal Replacement Therapy on Mortality in Critically Ill Patients With Acute Kidney Injury: The ELAIN Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12394945" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23932821" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Earlier-start versus usual-start dialysis in patients with community-acquired acute kidney injury: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32668114" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30304656" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Timing of Renal-Replacement Therapy in Patients with Acute Kidney Injury and Sepsis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18492867" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Intensity of renal support in critically ill patients with acute kidney injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19846848" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Intensity of continuous renal-replacement therapy in critically ill patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27449661" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Comparison of Urine Output among Patients Treated with More Intensive Versus Less Intensive RRT: Results from the Acute Renal Failure Trial Network Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1113451" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Factors influencing sodium and water excretion in uremic man.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7271950" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Nephron heterogeneity in polyuric acute renal failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15708100" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Once versus three-times daily regimens of tobramycin treatment for pulmonary exacerbations of cystic fibrosis--the TOPIC study: a randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30422153" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With Outcomes After Acute Kidney Injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32916177" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Renin-angiotensin aldosterone inhibitor use at hospital discharge among patients with moderate to severe acute kidney injury and its association with recurrent acute kidney injury and mortality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33272913" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Prospective Cohort Study of Renin-Angiotensin System Blocker Usage after Hospitalized Acute Kidney Injury.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
